Brief: CollabRx announces a partnership with Cartagenia Inc
Nov 10 (Reuters) - CollabRx Inc CLRX.O : * Collabrx and Cartagenia partner in interpretation support and reporting of genetic sequencing-based tests for cancer * Collabrx's genetic variant annotation (gva) service will be integrated with cartagenia's bench for oncology software platform * Source text for Eikon ID:nGNXVCARRa * Further company coverage CLRX.O ((Bangalore Newsroom; +1 646 223 8780))
Recent news on Rennova Health
See all newsBrief: Rennova Health Announces Stock Exchange Agreements With Foxo Technologies For Two Operating Subsidiaries
Brief: Foxo Technologies Enters Into Share Exchange Agreements To Acquire Healthcare Operations From Rennova Health, Inc.
Brief: Rennova Health, Inc. Announces Reverse Stock Split
Brief: Rennova Health Says Purchased, Taken Delivery Of Equipment To Provide Rapid Testing For COVID-19 At 3 Sites
Brief: Rennova Health Completes Agreement To Sell West Palm Beach-Based Clinical Laboratory